Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 10,300 shares, an increase of 1,371.4% from the December 15th total of 700 shares. Approximately 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 54,500 shares, the short-interest ratio is currently 0.2 days.
Arbor Rapha Capital Bioholdings Corp. I Price Performance
Shares of ARCK stock opened at $11.90 on Wednesday. Arbor Rapha Capital Bioholdings Corp. I has a one year low of $9.93 and a one year high of $15.59. The company has a 50 day moving average price of $10.93 and a 200 day moving average price of $10.41.
Get
Arbor Rapha Capital Bioholdings Corp. I alerts:
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Elequin Capital LP acquired a new stake in shares of Arbor Rapha Capital Bioholdings Corp. I in the 3rd quarter worth about $25,000. Mint Tower Capital Management B.V. bought a new position in shares of Arbor Rapha Capital Bioholdings Corp. I during the 3rd quarter valued at about $818,000. Parallax Volatility Advisers L.P. acquired a new position in shares of Arbor Rapha Capital Bioholdings Corp. I in the third quarter worth about $877,000. Balyasny Asset Management LLC boosted its holdings in shares of Arbor Rapha Capital Bioholdings Corp. I by 12.5% in the third quarter. Balyasny Asset Management LLC now owns 225,005 shares of the company's stock worth $2,277,000 after buying an additional 25,005 shares during the period. Finally, Saba Capital Management L.P. boosted its holdings in shares of Arbor Rapha Capital Bioholdings Corp. I by 18.1% in the third quarter. Saba Capital Management L.P. now owns 1,631,601 shares of the company's stock worth $16,512,000 after buying an additional 250,000 shares during the period. 68.70% of the stock is currently owned by hedge funds and other institutional investors.
About Arbor Rapha Capital Bioholdings Corp. I
(Get Rating)
Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector.
See Also
- Get a free copy of the StockNews.com research report on Arbor Rapha Capital Bioholdings Corp. I (ARCK)
- Insulet Has Potential To Gain More Than Analysts Are Forecasting
- Cathie Wood Is Buying These Stocks, Should You?
- Thor Industries Hammered Its Numbers. Is it a Buy?
- Tritium Is the Largest DC EV Charger Maker You've Never Heard Of
- United Airlines Soars Ahead of Earnings...Time to Deplane?
Receive News & Ratings for Arbor Rapha Capital Bioholdings Corp. I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbor Rapha Capital Bioholdings Corp. I and related companies with MarketBeat.com's FREE daily email newsletter.
Arbor Rapha Capital BioHoldings Corp.I(ナスダック：ARCK−GET格付け)は12月に空株数が大幅に上昇する目標である。12月30日現在、空頭株数は10300株で、12月15日の700株より1371.4%増加した。同社の約0.1%の株が空売りされた。1日平均出来高5万4千5千株で計算すると、現在の短利比率は0.2日である
Arbor Rapha Capital BioHoldings Corp.I価格表現
Arckの株は水曜日の寄り付きで11.90ドルをつけた。Arbor Rapha Capital BioHoldings Corp.Iの年間安値は9.93ドル，年間高位は15.59ドルであった。同社の50日移動平均価格は10.93ドル，200日移動平均価格は10.41ドルである
それを手に入れて
Arbor Rapha Capital BioHolding Corp警報：
機関資金の流入と流出
いくつかの機関投資家とヘッジファンドは最近、同社での彼らの頭を調整した。Elequin Capital LPは第3四半期にArbor Rapha Capital BioHoldings Corp.Iの約25，000ドルの新株を買収した。鋳貨塔資本管理会社(Mint Tower Capital Management B.V.)は第3四半期にArbor Rapha Capital BioHoldings Corp.Iの新頭寸を購入し，約818，000ドルの価値があった。Parallax Volatility Advisers L.P.は第3四半期にArbor Rapha Capital BioHoldings Corp.Iの約87.7万ドルの新株を買収した。Balyasny Asset Management LLCは第3四半期にArbor Rapha Capital BioHoldings Corp.Iの株12.5%を増資した。Balyasny Asset Management LLCは現在225，005株の同社株を保有しており，2，277，000ドルの価値があり，その間に25，005株を購入した。最後に，Saba Capital Management L.P.は第3四半期に保有するArbor Rapha Capital BioHoldings Corp.Iの株を18.1%増加させた。Saba Capital Management L.P.はその間に250，000株を購入し，現在1，631，601株の同社株を持ち，16，512，000ドルの価値がある。68.70%の株式は現在ヘッジファンドおよび他の機関投資家によって所有されている
Arbor Raphaについて
(格付けを取得する)
Arbor Rapha Capital BioHoldings Corp.Iには重大な業務がない。会社は、1つまたは複数の企業との合併、資本交換、資産買収、株式購入、再編、または同様の業務合併に集中している。それは生物製薬産業の買収機会を決定するつもりだ。
別項参照
- Arbor Rapha Capital BioHoldings Corp.I(Arck)に関するStockNews.comの研究報告を無料で取得
- Insuletにはアナリストの予測を超える収益を得る潜在力がある
- キャシー·ウッドは株を買っていますが、そうすべきですか？
- 雷神工業はその業績に大きな打撃を与えた。これは買ってきたのですか。
- あなたが聞いたことのない最大のDC電気自動車充電器メーカーです
- ユナイテッド航空は利益が上がる前に飛行機から降りる時ですか？
Arbor Rapha Capital BioHoldings Corp.I Dailyのニュースと評価を獲得しました-MarketBeat.comの無料毎日電子メール時事通信を介して、Arbor Rapha Capital BioHoldings Corp.Iおよび関連会社の最新のニュースおよびアナリスト格付けの毎日の簡単な要約を以下に入力します。
